Perrigo And Sol-Gel Face Up To Duobrii Lawsuit

ANDA Filed By Perrigo In July

 
• By Dean Rudge

Collaboration partners Perrigo and Sol-Gel Technologies face legal action stemming from Perrigo’s filing of an ANDA for generic Duobrii lotion for the treatment of plaque psoriasis in adults.

Gavel
Perrigo sent the originator a Paragraph IV patent challenge certification on 23 July • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin